Health Monitoring in Mayotte. Bulletin of February 20, 2026.

Key Points

Chikungunya

  • Significant increase in chikungunya cases in week 07-2026, with 74 cases recorded, representing more than 40% of all cases reported since the beginning of the year (175 cases). Transition to phase 2B of the ORSEC arbovirus response plan in week 07, corresponding to the pre-epidemic phase

Bronchiolitis

  • The bronchiolitis epidemic continues at a high intensity level throughout the country

Smallpox B (Mpox)

  • Ten confirmed cases of Mpox have been reported in Mayotte since the beginning of 2026, including 7 locally acquired cases and 3 cases imported from Madagascar. No new cases of Mpox in S08.

In relation to

Our latest news

news

Etienne Pot Appointed Interim Director General of Santé publique France

news

Arboviral Diseases in 2026: Mosquito-Borne Diseases Continue to Spread This...

news

Andes Hantavirus: Implementation of epidemiological investigations and...